150 related articles for article (PubMed ID: 24825067)
41. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
[TBL] [Abstract][Full Text] [Related]
42. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
43. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I
J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285
[TBL] [Abstract][Full Text] [Related]
44. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.
Diosdado B; van de Wiel MA; Terhaar Sive Droste JS; Mongera S; Postma C; Meijerink WJ; Carvalho B; Meijer GA
Br J Cancer; 2009 Aug; 101(4):707-14. PubMed ID: 19672269
[TBL] [Abstract][Full Text] [Related]
45. No association between mitochondrial DNA copy number and colorectal adenomas.
Thyagarajan B; Guan W; Fedirko V; Barcelo H; Tu H; Gross M; Goodman M; Bostick RM
Mol Carcinog; 2016 Aug; 55(8):1290-6. PubMed ID: 26258394
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor.
Islam F; Gopalan V; Vider J; Wahab R; Ebrahimi F; Lu CT; Kasem K; Lam AKY
Exp Cell Res; 2017 Aug; 357(2):260-270. PubMed ID: 28549913
[TBL] [Abstract][Full Text] [Related]
48. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
49. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
[TBL] [Abstract][Full Text] [Related]
50. Underpinning the repurposing of anthracyclines towards colorectal cancer: assessment of topoisomerase II alpha gene copy number alterations in colorectal cancer.
Nygård SB; Christensen IJ; Smith DH; Nielsen SL; Jensen NF; Nielsen HJ; Vainer B; Brünner N
Scand J Gastroenterol; 2013 Dec; 48(12):1436-43. PubMed ID: 24138107
[TBL] [Abstract][Full Text] [Related]
51. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
52. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II).
Baretton GB; Vogt M; Müller C; Diebold J; Schneiderbanger K; Schmidt M; Löhrs U
Scand J Gastroenterol; 1996 May; 31(5):481-9. PubMed ID: 8734346
[TBL] [Abstract][Full Text] [Related]
54. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
57. Biology of colorectal and gastric cancer cell lines.
Park JG; Gazdar AF
J Cell Biochem Suppl; 1996; 24():131-41. PubMed ID: 8806095
[TBL] [Abstract][Full Text] [Related]
58. DNA index shift with disease progression in colorectal adenocarcinoma: a morphological and flow cytometric study.
Scott CA; Desinan L; Avellini C; Bardus P; Rimondi G; Rizzi V; Beltrami CA
Hum Pathol; 1998 May; 29(5):482-90. PubMed ID: 9596272
[TBL] [Abstract][Full Text] [Related]
59. Mitochondrial genome instability in colorectal adenoma and adenocarcinoma.
de Araujo LF; Fonseca AS; Muys BR; Plaça JR; Bueno RB; Lorenzi JC; Santos AR; Molfetta GA; Zanette DL; Souza JE; Valente V; Silva WA
Tumour Biol; 2015 Nov; 36(11):8869-79. PubMed ID: 26069104
[TBL] [Abstract][Full Text] [Related]
60. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
